Cannamedical Pharma GmbH
| ISIN | 🆔 |
|---|---|
| Industry | Medicinal Cannabis, Pharmacy |
| Founded 📆 | 2016 |
| Founder 👔 | |
| Headquarters 🏙️ | Cologne, Germany |
Area served 🗺️ | |
Key people | David Henn[1] |
| Products 📟 | cannabis, extracts, dronabinol and medical products |
| Members | |
Number of employees | 35 (2020)[1] |
| 🌐 Website | www.cannamedical.com |
| 📇 Address | |
| 📞 telephone | |
Cannamedical Pharma GmbH is a wholesaler, importer and pharmaceutical manufacturer of medicinal cannabis based in Cologne, Germany. The company covers about a quarter of the demand for medicinal cannabis flowers in Germany.[1][2]
History[edit]
Cannamedical Pharma GmbH was founded by David Henn in November 2016. The following year, cannabis was released for therapeutic purposes in Germany.[3] Cannamedical's first round of financing took place that year, with Fabian Thylmann investing around one million euros in the company.[4] Initially, Cannamedical sourced cannabis flowers from the Netherlands. In October 2018, the company entered into its first major agreement with Canadian Wayland Group for an import of up to nine tonnes of cannabis flowers over a term of three years.[5] In early 2019, Cannamedical received 15 million euros in another round of funding from US and Germany-based private equity firm Orkila Capital LLC, which was the largest equity investment in a European cannabis startup at the time.[6] In September 2019, Cannamedical imported half a ton of cannabis by air from Portugal, which was the largest amount of a single import to Germany at the time.[7] In 2021, Cannamedical Pharma merged with PS Pharma, a manufacturer and logistics service provider in the narcotics industry. Semdor Pharma Group GmbH was founded as the parent company. Both companies continued to operate independently.[8] In 2022, the company recorded a share of around 25% of the German Cannabis market.[1][2]
Corporate structure[edit]
Since 2021, Cannamedical Pharma GmbH has been a subsidiary of Semdor Pharma Group GmbH. The managing director and founder of Cannamedical Pharma GmbH is David Henn. In 2022, the group employed 200 people and had an annual turnover of 60 million euros.[9] The company is headquartered in Cologne, Germany, with another branch in the UK.[10]
Services and Products[edit]
Cannamedical Pharma acts as a wholesaler and buys from various cannabis producers. As part of the Semdor Pharma Group, Cannamedical Pharma is involved in product research, storage and distribution of medicinal cannabis to the European market.[8] The company supplies medicinal cannabis to clinical facilities and pharmacies. Furthermore, the company provides consulting services for physicians for the treatment with cannabis.[11] Products include cannabis flowers, extracts, dronabinol and medical products. Cannamedical has the largest range of cannabis products on the German market.[12][13] Cannabis flowers are imported from Canada, Portugal, Australia and the Netherlands.[3] Furthermore, the company obtains supplies from Portugal through the US company Tilray.[10]
References[edit]
- ↑ 1.0 1.1 1.2 1.3 "Cannamedical Pharma GmbH Jahresabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020" [Cannamedical Pharma GmbH - Annual financial statements for the financial year from 01.01.2020 to 31.12.2020]. Bundesanzeiger (in Deutsch). 2022-01-05.
- ↑ 2.0 2.1 "Cannamedical Pharma steigert Qualität durch Cannabis-Sommelier". Saarbrücker Zeitung (in Deutsch). 2023-02-03. Retrieved 2023-04-01.
- ↑ 3.0 3.1 Telgheder, Maike (2021-04-15). "Cannamedical: Wie ein deutscher Cannabis-Pionier zum Spezialisten für Schmerzmedizin wird" [Cannamedical: How a German cannabis pioneer becomes a specialist in pain medicine]. Handelsblatt (in Deutsch). Retrieved 2023-07-07.
- ↑ Ksienrzyk, Lisa (2018-01-02). "Youporn-Macher investiert in Kölner Cannabis-Startup" [Youporn creater invests in Cologne cannabis start-up]. Business Insider (in Deutsch). Retrieved 2023-07-07.
- ↑ Blasius, Helga (2018-10-15). "Großer Medizinalcannabis-Import aus Kanada geplant" [Major medical cannabis import from Canada planned]. Deutsche Apotheker Zeitung (in Deutsch). Retrieved 2023-07-07.
- ↑ Loritz, Mary (2019-01-31). "Cologne-based startup Cannamedical raises €15 million to sell medical marijuana across Europe". EU-Startups. Retrieved 2023-07-07.
- ↑ Geyer, Tim (2020-04-20). "David Henn importiert tonnenweise Weed nach Deutschland und verdient damit Millionen" [David Henn imports tons of weed into Germany and earns millions with it]. Vice (in Deutsch). Retrieved 2023-07-07.
- ↑ 8.0 8.1 "Merger! Aus Cannamedical und PS Gruppe wird Semdor Pharma" [Merger! Cannamedical and PS Group become Semdor Pharma]. Krautinvest (in Deutsch). 2021-01-21. Retrieved 2023-07-07.
- ↑ "Semdor Pharma Group". Semdor Pharma Group GmbH (in Deutsch). 12 February 2021. Retrieved 2023-07-07.
- ↑ 10.0 10.1 Schlegel, Marion (2019-08-21). "Aurora Cannabis, Tilray & Co: Das tut sich in Deutschland" [Aurora Cannabis, Tilray & Co: What's happening in Germany]. Der Aktonär (in Deutsch). Retrieved 2023-07-07.
- ↑ Kanning, Tim (2019-03-25). "Wie David Henn sich auf dem Cannabismarkt etabliert hat" [The man with the grass]. Frankfurter Allgemeine Zeitung (in Deutsch). ISSN 0174-4909. Retrieved 2023-07-07.
- ↑ Glasmann, Dieter Klaus (2022-08-03). "Neue Cannamedical Strains in den Apotheken" [New Cannamedical Strains in the Pharmacies]. Hanf Magazin (in Deutsch). Retrieved 2023-07-07.
- ↑ Grotenhermen, Franjo; Timte, Petra (2022-05-11). "Cannabissorten in Deutschland und ihre Inhaltsstoffe" [Cannabis varieties in Germany and their ingredients]. Arbeitsgemeinschaft Cannabis als Medizin e. V. (in Deutsch). Retrieved 2023-07-07.
External links[edit]
This article "Cannamedical Pharma" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Cannamedical Pharma. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
